Citizens Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.1M | Sell |
38,786
-1,423
| -4% | -$772K | 0.27% | 78 |
|
|
2025
Q4 | $23.3M | Sell |
40,209
-305
| -0.8% | -$172K | 0.31% | 64 |
|
|
2025
Q3 | $19.7M | Buy |
40,514
+6,789
| +20% | +$3.16M | 0.27% | 76 |
|
|
2025
Q2 | $13.7M | Buy |
33,725
+4,736
| +16% | +$1.98M | 0.22% | 91 |
|
|
2025
Q1 | $14.4M | Sell |
28,989
-719
| -2% | -$389K | 0.28% | 78 |
|
|
2024
Q4 | $15.5M | Buy |
29,708
+1,892
| +7% | +$1.04M | 0.3% | 70 |
|
|
2024
Q3 | $17.2M | Buy |
27,816
+443
| +2% | +$262K | 0.35% | 60 |
|
|
2024
Q2 | $15.1M | Buy |
27,373
+8,491
| +45% | +$4.86M | 0.34% | 62 |
|
|
2024
Q1 | $11M | Buy |
18,882
+773
| +4% | +$434K | 0.37% | 55 |
|
|
2023
Q4 | $9.61M | Buy |
18,109
+6
| +0% | +$2.9K | 0.33% | 66 |
|
|
2023
Q3 | $9.16M | Sell |
18,103
-8,585
| -32% | -$4.57M | 0.37% | 60 |
|
|
2023
Q2 | $13.9M | Sell |
26,688
-377
| -1% | -$203K | 0.51% | 43 |
|
|
2023
Q1 | $15.6M | Sell |
27,065
-385
| -1% | -$217K | 0.57% | 35 |
|
|
2022
Q4 | $15.1M | Sell |
27,450
-7,972
| -23% | -$4.22M | 0.59% | 34 |
|
|
2022
Q3 | $18M | Sell |
35,422
-113
| -0.3% | -$63.2K | 0.8% | 27 |
|
|
2022
Q2 | $19.3M | Sell |
35,535
-646
| -2% | -$356K | 0.81% | 27 |
|
|
2022
Q1 | $21.4M | Sell |
36,181
-7,029
| -16% | -$4.04M | 0.75% | 26 |
|
|
2021
Q4 | $28.8M | Sell |
43,210
-1,215
| -3% | -$759K | 0.97% | 21 |
|
|
2021
Q3 | $25.4M | Sell |
44,425
-8,164
| -16% | -$4.48M | 0.94% | 21 |
|
|
2021
Q2 | $26.5M | Buy |
52,589
+366
| +0.7% | +$173K | 1.15% | 20 |
|
|
2021
Q1 | $23.8M | Sell |
52,223
-327
| -0.6% | -$156K | 1.26% | 16 |
|
|
2020
Q4 | $24.5M | Sell |
52,550
-749
| -1% | -$351K | 1.4% | 15 |
|
|
2020
Q3 | $23.5M | Buy |
53,299
+526
| +1% | +$217K | 1.5% | 13 |
|
|
2020
Q2 | $19.1M | Sell |
52,773
-716
| -1% | -$240K | 1.34% | 18 |
|
|
2020
Q1 | $15.2M | Sell |
53,489
-1,715
| -3% | -$541K | 1.24% | 21 |
|
|
2019
Q4 | $17.9M | Sell |
55,204
-1,747
| -3% | -$530K | 1.2% | 17 |
|
|
2019
Q3 | $16.6M | Sell |
56,951
-895
| -2% | -$256K | 1.2% | 18 |
|
|
2019
Q2 | $17M | Buy |
57,846
+9,681
| +20% | +$2.67M | 1.24% | 16 |
|
|
2019
Q1 | $13.2M | Buy |
48,165
+347
| +0.7% | +$86.4K | 0.97% | 28 |
|
|
2018
Q4 | $10.7M | Sell |
47,818
-525
| -1% | -$123K | 0.97% | 34 |
|
|
2018
Q3 | $11.8M | Sell |
48,343
-570
| -1% | -$131K | 0.93% | 33 |
|
|
2018
Q2 | $10.1M | Sell |
48,913
-1,100
| -2% | -$233K | 0.85% | 36 |
|
|
2018
Q1 | $10.3M | Sell |
50,013
-3,807
| -7% | -$799K | 0.87% | 39 |
|
|
2017
Q4 | $10.2M | Buy |
53,820
+95
| +0.2% | +$18.2K | 0.82% | 43 |
|
|
2017
Q3 | $10.2M | Sell |
53,725
-1,579
| -3% | -$286K | 0.87% | 40 |
|
|
2017
Q2 | $9.65M | Sell |
55,304
-1,354
| -2% | -$227K | 0.85% | 40 |
|
|
2017
Q1 | $8.7M | Buy |
56,658
+6,206
| +12% | +$949K | 0.77% | 50 |
|
|
2016
Q4 | $7.12M | Sell |
50,452
-2,276
| -4% | -$336K | 0.69% | 57 |
|
|
2016
Q3 | $8.39M | Sell |
52,728
-127
| -0.2% | -$19.6K | 0.79% | 52 |
|
|
2016
Q2 | $7.81M | Sell |
52,855
-742
| -1% | -$110K | 0.75% | 55 |
|
|
2016
Q1 | $7.59M | Buy |
53,597
+3,621
| +7% | +$485K | 0.73% | 56 |
|
|
2015
Q4 | $7.41M | Buy |
+49,976
| New | +$6.67M | 0.7% | 58 |
|
Other funds holding TMO
VCM
Citizens Financial Group's TMO Position: Q1 2026 in Review
Citizens Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q1 2026, selling an estimated $772K and leaving 38,786 shares worth $19.1M. The position accounts for 0.27% of the portfolio, ranked #78.
Citizens Financial Group first reported a position in TMO in Q4 2015 and has held it in 42 quarters since. The position peaked at $28.8M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Citizens Financial Group held 38,786 shares of Thermo Fisher Scientific worth $19.1M as of Q1 2026.
- Citizens Financial Group sold 1,423 Thermo Fisher Scientific shares in Q1 2026, an estimated $772K.
- Thermo Fisher Scientific made up 0.27% of Citizens Financial Group's portfolio in Q1 2026, its #78 holding.
- Citizens Financial Group first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 42 quarters since.
- Citizens Financial Group's Thermo Fisher Scientific position peaked at $28.8M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.